Disability Improvement as a Clinically Relevant Outcome in Clinical Trials of Relapsing MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Disability Improvement as a Clinically Relevant Outcome in Clinical Trials of Relapsing Forms of Multiple Sclerosis
Mult. Scler. 2021 Mar 26;[EPub Ahead of Print], BA Cree, JA Cohen, AT Reder, D Tomic, D Silva, D Piani Meier, AK Laflamme, S Ritter, D Leppert, L KapposFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.